We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ELLXF market cap is 33.31M. The company's latest EPS is AUD -0.0058 and P/E is 0.00.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 32.47M | 15.6M | 11.76M | 7.57M | 8.83M |
Operating Income | -88.6M | -100M | -17.05M | -10.51M | -7.62M |
Net Income | -82.93M | -104.51M | -17.03M | -10.57M | -7.51M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 121.07M | 42.47M | 25.33M | 13.49M | 11.71M |
Total Liabilities | 9.69M | 6.82M | 6.26M | 4.33M | 5.25M |
Total Equity | 111.38M | 35.65M | 19.08M | 9.16M | 6.46M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -51.07M | -22.62M | -14.07M | -8.15M | -2.76M |
Investing | -17.93M | 2.55M | 172k | -869k | -1.04M |
Financing | 46.44M | 27.55M | -1.16M | -757k | 1.61M |
Market Cap | 33.31M |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 1.3B |
Average Volume (1 week) | 1.3k |
Average Volume (1 Month) | 15.72k |
52 Week Change | 228.21% |
52 Week High | 0.0211 |
52 Week Low | 0.0003 |
Spread (Intraday) | 0 (0%) |
Company Name | Elixinol Wellness Ltd (PK) |
Address |
level 12 sydney, new south wales 2000 |
Website | https://elixinolglobal.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions